Please login to the form below

Not currently logged in
PMLiVE Top Pharma List


The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Celebrex was produced by Pfizer.

COX-2 advertising clampdown

Celebrex and Vioxx were once among the most heavily advertised prescription medicines in the US. ... Pfizer spent 87m on Celebrex ads in 2003 and 71m in the first nine months of 2004.

FDA releases Champix warning

Celebrex plaintiff evidence submissions fail. In better news for Pfizer, a US District Court judge ruled on 19 November that plaintiffs had not submitted scientifically reliable evidence that Celebrex (celecoxib) causes ... Approximately 3, 000

Pharma news in brief

Pfizer shares rebounded. Shares in Pfizer bounced back as positive results from a new study found its arthritis drug Celebrex, a COX-2 inhibitor, did not increase cardiovascular problems. ... The National Institute of Health has reported in an

FDA retreats over banned report

Dr Graham's research sought to discover the risk of suffering cardiovascular disease, such as strokes, heart disease and heart attacks, in patients taking Vioxx, Celebrex (a similar, COX-2 drug ... Celebrex saferÖ. According to Dr Graham's paper, he

FDA issues risk guidance

Meanwhile, new FDA Advisory Committee recommendations around the COX-2 class of painkillers could work to the advantage of Pfizer's Bextra and Celebrex but to the detriment of Merck's ... The advisory committee recommended in February that Celebrex and

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs


Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...